Preview

Healthcare

Advanced search
No 9 (2026)
View or download the full issue PDF (Russian)

INNOVATIVE MEDICAL TECHNOLOGIES

4-15 158
Abstract

Objective. To analyse current global trends in scientific research in obstetrics and gynaecology, neonatology, paediatrics and medical genetics and to substantiate priority directions for national science in these fields of medicine.

Materials and methods. A scoping review was conducted following the PRISMA-ScR (Preferred Reporting Items For Systematic Reviews And Meta-Analyses Extension For Scoping Reviews) methodology. Searches were performed in PubMed, Scopus and Web of Science for the period January 2019  –  July 2026 (last search date: 31 July 2026). The search query combined the terms “precision medicine”, “artificial intelligence”, “machine learning”, “preeclampsia”, “fetal growth restriction”, “assisted reproduction”, “endometrial receptivity”, “newborn screening”, and “prenatal exome/genome sequencing” using AND/OR operators. Inclusion criteria: original studies, systematic reviews and meta-analyses in English or Russian. Exclusion criteria: individual case reports and publications without full-text access. National and international policy documents were additionally analysed. Source selection was performed independently by three reviewers; data synthesis was qualitative (narrative) with thematic grouping.

Results. The key vectors of global perinatal medicine transformation were identified: application of artificial intelligence for early detection of pregnancy complications (AUC = 0.85–0.95 in pre-eclampsia and fetal growth restriction prediction systems); expansion of genomic neonatal screening to cover more than 36 conditions; implementation of exome and genome sequencing in prenatal diagnosis (incremental diagnostic yield 11.0–29.5 % compared with chromosomal microarray analysis); and personalisation of assisted reproductive technologies based on multiparametric omics studies. The achievements of the Republic of Belarus in 2025 (infant mortality 2.4 ‰, perinatal mortality 3.68 ‰, survival rate of extremely low birth weight newborns 84.0 %) are consistent with global trends.

Conclusion. The implementation of the subprogram “Obstetrics, Gynecology, Pediatrics and Medical Genetics” of the State Scientific and Technical Program “Innovative Technologies in Medicine” (2026–2030) is aimed at advancing translational research and integrating precision medicine technologies into clinical practice.

SCIENTIFIC RESEARCH AND DEVELOPMENT

16-23 127
Abstract

Objective. To examine clinical and psychological variables associated with hostility and anger and to assess the association of documented treatment nonadherence with subtherapeutic or undetectable antipsychotic concentrations in blood plasma in patients with schizophrenia and a history of aggressive behavior.

Materials and methods. A two-component observational study was conducted in two independent samples. The inpatient component included 56 patients assessed with PANSS, AIHQ, DAI-30, and other standardized instruments. The outpatient component included 63 patients receiving antipsychotic treatment; 45 had no documented history of treatment nonadherence and 18 had such a history. Plasma antipsychotic concentrations were measured using high-performance liquid chromatography with high-resolution mass spectrometric detection. Bonferroni correction was applied to 36 correlation tests (adjusted significance threshold, 0.0014).

Results. After correction for multiple testing, hostility and anger indices remained significantly associated with positive, negative, general psychopathology and supplementary PANSS scores, the PANSS total score, and scale 4 (Psychopathic Deviate) of the MiniMult inventory. In the outpatient sample, subtherapeutic or undetectable antipsychotic concentrations in blood plasma were found in 13 (72.2 %) of 18 patients with documented treatment nonadherence and in 17 (37.8 %) of 45 patients without such a history (χ² = 6.115, p = 0.013).

Conclusions. Therapeutic drug monitoring provides an objective measure of antipsychotic exposure and complements clinical assessment of adherence. These findings do not establish a causal effect of drug concentration on aggressive behavior and do not support the use of therapeutic drug monitoring as a stand-alone violence prediction tool.

24-34 153
Abstract

Objective. To characterize clinical severity of COVID-19 in hospitalized patients during pandemic periods and to assess the effect of vaccination on disease course.

Materials and methods. Single-centre retrospective cohort study of 11,203 patients hospitalized with COVID-19 in 2020– 2023 (112,455 bed-days). Clinical severity was graded on a four-level respiratory failure scale: «none»; «oxygen mask/cannula»; «noninvasive ventilation» (NIV); «invasive mechanical ventilation» (IMV). Bayesian hierarchical ordinal regression was fitted with covariates: age, Elixhauser comorbidity index, vaccination, previous-day respiratory failure, pandemic day and disease days. Statistical analysis was performed with programming languages R 4.6.0 and Stan 2.38.0.

Results. The 28-day cumulative risk of respiratory failure was up to 50 % in the first wave, up to 80 % in the period of Alpha variant predominance, > 90 % (unvaccinated) and ≤ 65 % (vaccinated) in the period of Delta variant predominance, and ≤ 25 % in the Omicron. During predominance of Delta variant, the probability of NIV/IMV reached 25–30 % in older unvaccinated patients with comorbidities compared to ≤ 4.5 % in vaccinated ones; during predominance of Omicron variants it was < 1 %, though up to 20 % still required oxygen. After standardization, vaccination was associated with a lower cumulative risk from September 2021 to March 2022, peaking in December 2021: -24.3 % (95 % CI (-17,6; -30,6)).

Conclusion. Respiratory failure severity varied by pandemic period, and vaccination against SARS-CoV-2 had a protective effect in hospitalized patients.

35-44 135
Abstract

Objective. To evaluate the trends in healthcare-associated infection (HAI) rates and analyze the effectiveness of the infection control system in a surgical anesthesiology and intensive care unit (ICU) among patients undergoing abdominal surgeries and liver or kidney transplantation.

Materials and methods. A single-center prospective study was conducted at the ICU of the Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology. Over the period from 2019 to 2025, a total of 10,567 patients were treated (82.2 % – surgical profile, 30.6 % – post-transplant recipients). Epidemiological surveillance included registration of HAIs using standard case definitions, microbiological monitoring, and assessment of antimicrobial resistance. Data processing was performed using WHONET 5.6 and IBM SPSS Statistics 26.0 software.

Results. The overall incidence of healthcare-associated infections (HAIs) peaked in 2021 at 12.5 (95 % CI (9.7–15.5)) per 100 patients, then decreased to 5.6 in 2022 and stabilized in 2023–2025 at 4.6–5.9 per 100 treated patients. The rate of ventilatorassociated pneumonia decreased from 27.3 (2021) to 12.8 (2025) per 1000 ventilator-days (p = 0.04). The rate of surgical site infections decreased from 1.0 (2019) to 0.5 (2025) per 100 operations (p = 0.03). A shift in the timing of late-onset infections was noted (VAP – on day 10 of mechanical ventilation, CAUTI – on day 13 of catheterization). An increase in the proportion of Gram-positive flora (from 25 to 33 %, p = 0.06) and Candida fungi (Candida non-albicans – 58%, including C. auris – 31 %) was revealed. The proportion of imported cases was 21% (95 % CI (16.7–25.9)). An increase in the susceptibility of major Gram-negative pathogens to carbapenems and polymyxins was observed (p < 0.05 for most comparisons).

Conclusion. The implementation of epidemiological surveillance, adherence to infection control measures, and optimization of antimicrobial therapy are associated with a reduction in HAI incidence and the prevalence of carbapenem-resistant microorganisms, as well as with a mitigation of the consequences of imported epidemiologically significant pathogens.

PUBLIC HEALTH AND HEALTHCARE

45-56 138
Abstract

Objective. To assess the opinion of health, social service and non-state sector workers on the organisation of integrated care to citizens in need.

Materials and methods. The object of the study is represented by healthcare workers, social service providers, and employees of non governmental organisations that provide medical and social assistance (hereinafter referred to as respondents). The subject of the study is the respondents’ opinions on the organisation of integrated care in Belarus. The study used sociological (questionnaires) and statistical methods. The questionnaire Scaling Integrated Care in Context (SCIROCCO), developed within the project SCIROCCO Exchange EU Capacity Action for Integrated Care was used as a research tool, which is used in European countries to assess the readiness of the healthcare and social protection systems and non-governmental organizations to implement and deliver integrated care. The scope of the study was 411 respondents, most of whom have many years of experience and qualifications in providing medical care and social services, whose opinion allows us to assess the readiness of the healthcare and social protection system to implement an integrated approach in providing medical care and social services to citizens in need. The average work experience in healthcare organisations, social service institutions and non-governmental organizations providing medical and social assistance services among respondents was 17.7 (95 % CI (16.5–18.9)) years, almost 73 % of the respondents have a qualification category.

Results. Respondents' opinions on the readiness of the healthcare and social protection systems for transformations to develop integrated care were mixed. Nearly 71 % of respondents believe that the healthcare and social protection systems are ready for transformations to develop integrated care, 27.5 % are not ready, and approximately 2 % could not answer. The majority of respondents (91.2 %) unanimously agreed on the need to develop integrated care in the country, regardless of the study region or worker category (Chi-square test χ2 = 1.78, p = 1.8).

Conclusion. The majority of respondents (91.2 %) are interested in developing integrated care in the country. Nearly 71 % of respondents believe that the healthcare and social protection systems are ready for transformation to develop integrated care, but note that some areas related to regulatory frameworks for coordination and management of activities, financing, evaluation methodology, and digitalization require improvement.

57-67 159
Abstract

Objective. To identify problematic aspects of interagency collaboration between healthcare and social protection specialists based on an empirical analysis of survey data from professionals involved in developing the vocational and occupational rehabilitation section of the Individual Programme of Rehabilitation and Habilitation for Persons with Disabilities (IPRH), to assess factors associated with these challenges, and to propose recommendations for improving current practice.

Materials and methods. A total of 175 specialists were surveyed: expert physicians of the Medical Rehabilitation Expert Commission (MREC), specialists from MREC medical and vocational rehabilitation units, and employment and social protection specialists. The questionnaire comprised 39 items organized into eight blocks, with responses rated on a Likert scale. Statistical methods included Cronbach's alpha, Spearman correlation, standardization of group ratings, Kruskal – Wallis and Mann – Whitney U tests, dominant response category analysis, and content analysis.

Results. The most problematic block was the one addressing barriers to interagency collaboration, which ranked last and showed consistent negative correlations with the remaining blocks, indicating that the difficulties are organizational rather than role-related or methodological in nature. Length of professional experience had no significant effect. MREC expert physicians participate in IPRH development predominantly on an ongoing basis, whereas employment and social protection specialists participate episodically, which limits their input on highly specialized matters.

Сonclusion. Efforts to improve collaboration should focus on interagency coordination, standardization of information exchange, and more consistent inclusion of employment and social protection specialists in developing the vocational and occupational rehabilitation section of the IPRH.

MEDICINAL PRODUCTS AND MEDICAL DEVICES

68-78 116
Abstract

This article presents modern approaches to the development of innovative oral solid dosage forms, of which tablets and capsules are of particular interest. Currently, tablets that release active ingredients in the oral cavity are being developed. Among such tablets, freeze-dried tablets deserve particular attention; they are characterised by rapid solubility and can provide both local and resorptive effects of the active ingredients. Freeze-drying and a variety of technological methods are used to produce freeze-dried tablets. Currently, tablets and capsules for oral administration with modified release of active ingredients in the gastrointestinal tract are being developed. Various approaches – technological, physical and chemical – are used to produce such tablets and capsules, and 3D-printing is also employed. The use of modified-release tablets and capsules makes it possible to regulate the delivery of medicines to the human body, reduce the quantities of active ingredients in medicinal products, minimise the occurrence of side effects, whilst still achieving a sufficient therapeutic effect from their use.

Objective. To characterise the various types of oral dosage forms available on the pharmaceutical market and to examine the application of different technological approaches to their development.

OBITUARY



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1027-7218 (Print)